<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04049188</url>
  </required_header>
  <id_info>
    <org_study_id>00019460</org_study_id>
    <secondary_id>20181015</secondary_id>
    <nct_id>NCT04049188</nct_id>
  </id_info>
  <brief_title>Access to Single-Fraction Palliative Radiation Therapy in Cancer Patients Enrolled in Hospice</brief_title>
  <acronym>SFPRT</acronym>
  <official_title>Impact of Access to Single-Fraction Palliative Radiation Therapy in Cancer Patients Enrolled in Hospice</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Care Partners</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>OHSU Knight Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Care Partners</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Feasibility study to report on the impact of ACCESS of single-fraction radiation therapy on
      cancer patients with bone metastases enrolled in hospice care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hospice care for terminally ill patients with metastatic cancer improves quality of life,
      pain control, and potentially also survival when patients are enrolled early.1-3 However,
      hospice programs are often seen by patients and their caregivers as the last resort after
      exhaustion of all effective treatment options. The need to revoke active treatment (for all
      hospice patients with cancer outside of the VA system) discourages hospice enrollment.

      This study aims to understand and analyze barriers to access specifically for short course
      palliative radiation therapy in cancer patients enrolled in hospice.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Opioid Use for Pain Management</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Opioid Dosage (mg/day)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improved Quality of Life Measures</measure>
    <time_frame>During study completion</time_frame>
    <description>Questionnaires using Herth Hope Index, Timed Up and Go, and Edmonton Symptom Assessment Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improved Activities of Daily Living</measure>
    <time_frame>During study completion</time_frame>
    <description>Questionnaires using Hearth Hope Index, Timed Up and Go, and Edmonton Symptom Assessment Scale</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">31</enrollment>
  <condition>Cancer Metastatic</condition>
  <arm_group>
    <arm_group_label>Single-Fraction Palliative RT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single-Fraction Palliative Radiation Therapy Adminstration</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Single-Fraction Palliative Radiation Therapy</intervention_name>
    <description>All subjects will be undergo single-fraction palliative radiation therapy who have cancer and associated bone metastases and symptomatic bone pain.</description>
    <arm_group_label>Single-Fraction Palliative RT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Solid Tumor Malignancies and Multiple Myeloma with Bone Metastases and Associated Bone
             Pain Enrolled in Hospice

        Exclusion Criteria:

          -  Decisionally-Impaired Subjects, Pregnant Women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Andy Kyler, BSN, MBA</last_name>
    <phone>5036192621</phone>
    <email>andy.kyler@carepartners.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christa Nicholas</last_name>
    <phone>5036469565</phone>
    <email>Christa.Nicholas@carepartnersor.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CarePartners</name>
      <address>
        <city>Hillsboro</city>
        <state>Oregon</state>
        <zip>97006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christa Nicholas</last_name>
      <phone>503-648-9565</phone>
    </contact>
    <investigator>
      <last_name>Andy Kyler, BSN, MBA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>March 5, 2019</study_first_submitted>
  <study_first_submitted_qc>August 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 8, 2019</study_first_posted>
  <last_update_submitted>January 21, 2020</last_update_submitted>
  <last_update_submitted_qc>January 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cancer Patients Hospice Care</keyword>
  <keyword>Palliative Radiation Therapy</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

